Journey Medical Corp (DERM)
3.93
+0.13
(+3.42%)
USD |
NASDAQ |
May 31, 16:00
3.93
0.00 (0.00%)
After-Hours: 20:00
Journey Medical Shareholders Equity (Quarterly): 12.95M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 12.95M |
| December 31, 2023 | 20.35M |
| September 30, 2023 | 17.37M |
| June 30, 2023 | 0.005M |
| March 31, 2023 | 7.492M |
| December 31, 2022 | 16.98M |
| September 30, 2022 | 26.18M |
| Date | Value |
|---|---|
| June 30, 2022 | 34.80M |
| March 31, 2022 | 41.44M |
| December 31, 2021 | 42.04M |
| September 30, 2021 | -11.71M |
| June 30, 2021 | -0.792M |
| December 31, 2020 | 10.29M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-11.71M
Minimum
Sep 2021
42.04M
Maximum
Dec 2021
16.72M
Average
16.98M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
| Fortress Biotech Inc | 23.02M |
| Stereotaxis Inc | 20.03M |
| GT Biopharma Inc | 5.312M |
| Cara Therapeutics Inc | 29.80M |
| FibroGen Inc | -228.12M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 66.57M |
| Total Liabilities (Quarterly) | 53.62M |
| Debt to Equity Ratio | 1.134 |
| Current Ratio | 1.207 |
| Net Debt Paydown Yield | 2.21% |